A detailed history of Gm Advisory Group, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Gm Advisory Group, Inc. holds 506 shares of VRTX stock, worth $238,002. This represents 0.02% of its overall portfolio holdings.

Number of Shares
506
Previous 537 5.77%
Holding current value
$238,002
Previous $224,000 5.8%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$392.81 - $485.53 $12,177 - $15,051
-31 Reduced 5.77%
506 $237,000
Q1 2024

May 09, 2024

BUY
$407.69 - $446.08 $218,929 - $239,544
537 New
537 $224,000
Q3 2023

Nov 13, 2023

BUY
$338.18 - $362.46 $270,205 - $289,605
799 New
799 $277,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $121B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Gm Advisory Group, Inc. Portfolio

Follow Gm Advisory Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gm Advisory Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gm Advisory Group, Inc. with notifications on news.